scholarly journals The Validity and Reliability of the Sinhala Translation of the Patient Health Questionnaire (PHQ-9) and PHQ-2 Screener

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Raveen Hanwella ◽  
Shakya Ekanayake ◽  
Varuni A. de Silva

The Patient Health Questionnaire (PHQ-9) was adapted and translated into Sinhala. Sample consisted of 75 participants diagnosed with MDD according to DSM-IV criteria and 75 gender matched controls. Concurrent validity was assessed by correlating total score of PHQ-9 with that of Centre for Epidemiological Studies Depression Scale (CESD). The Structured Clinical Interview for DSM-IV (SCID-II) conducted by a psychiatrist was the gold standard. Mean age of the sample was 33.0 years. There were 91 females (60.7%). There was significant difference in the mean PHQ-9 scores between cases (14.71) and controls (2.55) (P<0.001). The specificity of the categorical algorithm was 0.97; the sensitivity was 0.58. Receiver operating characteristic (ROC) analysis found that cut-off score of ≥10 had sensitivity of 0.75 and specificity of 0.97. The area under the curve (AOC) was 0.93. The sensitivity of the two-item screener (PHQ-2) was 0.80 and the specificity was 0.97. Cronbach’s alpha was 0.90. The PHQ-9 is a valid and reliable instrument for diagnosing MDD in a non-Western population. The threshold algorithm is recommended for screening rather than the categorical algorithm. The PHQ-2 screener has good sensitivity and specificity and is recommended as a quick screening instrument.

Diagnostica ◽  
2004 ◽  
Vol 50 (4) ◽  
pp. 171-181 ◽  
Author(s):  
Kerstin Gräfe ◽  
Stephan Zipfel ◽  
Wolfgang Herzog ◽  
Bernd Löwe

Zusammenfassung. Ziel dieser Studie ist die Validierung der deutschen Version des “Patient Health Questionnaire (PHQ-D)“. Der PHQ wurde zum praktikablen Screening psychischer Störungen für die Primärmedizin entwickelt und erfasst direkt die diagnostischen Kriterien des DSM-IV. N = 357 allgemeinmedizinische/internistische Patienten und N = 171 psychosomatische Patienten wurden mit dem PHQ-D und dem Strukturierten Klinischen Interview für DSM-IV (SKID-I) untersucht, wobei das SKID-I als diagnostischer Goldstandard diente. Ärzte und Patienten wurden zur Akzeptanz des PHQ-D befragt. Eine ausgezeichnete Kriteriumsvalidität des PHQ-D zeigte sich insbesondere bei der Diagnose der Major Depression, wo die Sensitivität für die medizinische Stichprobe bei 95% und die Spezifität bei 86% lag. Gute teststatistische Werte ergaben sich u.a. auch für die Panikstörung. Die Anwendung des PHQ-D wurde von jeweils mehr als 90% der Patienten und Ärzte gut akzeptiert. Mit dem PHQ-D liegt ein praktikables, valides und gut akzeptiertes Instrument zur Anwendung in Forschung und klinischer Praxis vor. Sein Einsatz kann zur verbesserten Versorgung psychischer Störungen beitragen.


2013 ◽  
Vol 22 (1) ◽  
pp. 12-19 ◽  
Author(s):  
Anthony W. McGuire ◽  
Jo-Ann Eastwood ◽  
Aurelia Macabasco-O'Connell ◽  
Ron D. Hays ◽  
Lynn V. Doering

BackgroundDepression screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear.ObjectivesTo evaluate nurse-administered versions of the Patient Health Questionnaire for depression screening in patients hospitalized for acute coronary syndrome.MethodsStaff nurses in an urban cardiac care unit administered versions 2, 9, and 10 of the questionnaire to 100 patients with acute coronary syndrome. The Depression Interview and Structured Hamilton was administered by advanced practice nurses blinded to the results of the Patient Health Questionnaire. With the results of the Depression Interview and Structured Hamilton as a criterion, receiver operating characteristic analyses were done for each version of the Patient Health Questionnaire. The Delong method was used for pairwise comparisons. Cutoff scores balancing false-negatives and false-positives were determined by using the Youden Index.ResultsEach version of the questionnaire had excellent area-under- the-curve statistics: 91.2%, 92.6%, and 93.4% for versions 2, 9, and 10, respectively. Differences among the 3 versions were not significant. Each version yielded higher symptom scores in depressed patients than in nondepressed patients: version 2 scores, 3.4 vs 0.6, P = .001; version 9 scores, 13 vs 3.4, P &lt; .001; and version 10 scores, 14.5 vs 3.6, P &lt; .001.ConclusionsFor depression screening in hospitalized patients with acute coronary syndrome, the Patient Health Questionnaire 2 is as accurate as longer versions when administered by nurses. Further study is needed to determine if screening with this tool changes clinical decision making or improves outcomes in these patients.


2016 ◽  
Vol 78 (6) ◽  
pp. 716-727 ◽  
Author(s):  
Kurt Kroenke ◽  
Jingwei Wu ◽  
Zhangsheng Yu ◽  
Matthew J. Bair ◽  
Jacob Kean ◽  
...  

2018 ◽  
Author(s):  
Sarah Patrick ◽  
Peter Connick

AbstractBackgroundDepression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire (PHQ-9) is an attractive candidate for this role.ObjectiveTo synthesise published findings on the psychometric properties of the 9-item Patient Health Questionnaire (PHQ-9) when applied to people with multiple sclerosis (pwMS).Data sourcesPubMed, Medline and ISI Web of Science databases, supplemented by hand-searching of references from all eligible sources.Study eligibility criteriaPrimary literature written in English and published following peer-review with a primary aim to evaluate the performance of the PHQ-9 in pwMS.Outcome measuresPsychometric performance with respect to appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility.ResultsSeven relevant studies were identified, these were of high quality and included 5080 participants from all MS disease-course groups. Strong evidence was found supporting the validity of the PHQ-9 as a unidimensional measure of depression. Used as a screening tool for major depressive disorder (MDD) with a cut-point of 11, sensitivity was 95% sensitivity and specificity 88.3% (PPV 51.4%, NPV 48.6%). Alternative scoring systems that may address the issue of overlap between somatic features of depression and features of MS per se are being developed, although their utility remains unclear. However data on reliability was limited, and no specific evidence was available on test-retest reliability, responsiveness, acceptability, or feasibility.ConclusionsThe PHQ-9 represents a suitable tool to screen for MDD in pwMS. However use as a diagnostic tool cannot currently be recommended, and the potential value for monitoring depressive symptoms cannot be established without further evidence on test-retest reliability, responsiveness, acceptability, and feasibility.PROSPERO register ID: CRD42017067814


Psicologia ◽  
2019 ◽  
Vol 33 (2) ◽  
pp. 1-8
Author(s):  
Sara Monteiro ◽  
Ana Bártolo ◽  
Ana Torres ◽  
Anabela Pereira ◽  
Emília Albuquerque

The present study examines a new factor structure and the convergent validity of the Portuguese version of the Patient Health Questionnaire-9 (PHQ-9) with college students. This measure has been used to evaluate depressive symptoms in adults. The total sample included 958 college students. Data were collected from a Web-based survey carried out in schools forming the Polytechnic Institute of Coimbra. Students completed the PHQ-9 and Hospital Anxiety and Depression Scale (HADS) and Brief Symptom Inventory (BSI) subscales as convergent measures. Results pointed to good fit of a second-order factor model with three first-order factors (somatic, cognitive and affective dimensions of depression). Strong positive correlations were found between PHQ-9 scores and HADS depression and BSI depression subscales. Our findings reinforce the PHQ-9 as a valid tool in higher education settings. Future studies should re-examine the dimensional structure of the tool considering its implications for the clinical interpretation of the measure.


2019 ◽  
Vol 125 ◽  
pp. e1016-e1022 ◽  
Author(s):  
Marwa Summaka ◽  
Hiba Zein ◽  
Linda Abou Abbas ◽  
Charbel Elias ◽  
Elias Elias ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document